Dobri Kiprov
Co-founder and Chief Medical Officer of Lyfspn
Dr. Dobri Kiprov is a co-founder of Lyfspn and a practicing physician Board certified in Hemapheresis, internationally recognized for his pioneering work in the field of Therapeutic Apheresis.
Dr. Kiprov is the first physician to be Board Certified in Hemapheresis and has practiced for over 30 years.
Dr. Kiprov has more than 100 publications and his most recent research has established him as a leader in the prevention and treatment of age related medical conditions.
Dr. Kiprov served two terms on the American Society of Apheresis Board of Directors and created the first ASFA education video program.
He is the author of Lifestyle in Motion, a cookbook on how to boost your immune system, prevent diseases, defy aging, and control weight.
Visit website: https://www.dobrikiprov.com/
See also: 
Lyfspn
- Working to invent novel therapies that will allow us live longer, healthier lives.
Details last updated 10-Jun-2020
Dobri Kiprov is also referenced in the following:
Aging and Blood - Irina Conboy presentation for SENS Research Foundation
Part of a series organized by SENS Research Foundation's Education Department
Rejuvenation Startup Summit 2024
10-May-2024 to 11-May-2024
The leading networking event for rejuvenation startups, longevity investors and translational researchers by Forever Healthy Foundation
Dobri Kiprov News
The blood revolution: tapping into longevity
The San Francisco Standard - 05-Oct-2024
As therapeutic plasma exchange gains popularity, experts urge caution in the quest for eternal youth
Read more...Reason reports back from Rejuvenation Startup Summit 2024
Fight Aging! - 13-May-2024
A great summary of 25 speakers who are in various stages of platform building, drug discovery and clinical trials
Read more...Reason reports back from October's Rejuvenation Startup Summit
Fight Aging! - 19-Oct-2022
Some really exciting developments with quite a few in clinical trials
Read more...Lyfspn recruiting in USA for plasmapheresis trial using 5% human albumin
Longevity Technology - 08-Jun-2022
No mention of the Conboys, but it looks like it's based on their plasma dilution research
Read more...Therapeutic plasma exchange can have almost immediate benefit
NEO.LIFE - 24-Jun-2021
Lou Hawthorne, CEO of NaNotics, provides his account of TPE and feeling younger
Read more...Longevity Technology interviews Irina Conboy about blood plasma exchange
Longevity Technology - 29-Apr-2021
"Very promising" results from pilot study, with phase 3 clinical trial planned
Read more...Human trial results of blood plasma exchange for Alzheimer's
Aging Matters - 29-Jun-2020
Benefits were seen, but overall results are not impressive
Read more...Diluting blood rejuvenates old tissues in mice
Aging Matters - 08-Jun-2020
There are things in blood that drives our ageing
Read more...
